Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Financings In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Molecular diagnostics firm AutoGenomics seeks to raise up to $65 million in an initial public offering. IlluminOss raises $28 mil. for fracture repair device. LoneStar Heart gets $20 million for heart failure implant. More financings.

You may also be interested in...



People Briefs: Appointments At Vision-Sciences, Positron, NanoString Technologies and Illuminoss Medical

Vision-Sciences promotes interim chief to CEO and president. Positron names president. Medical device inventor and entrepreneur Thomas J. Fogarty joins SinuSys board. More people briefs.

People Briefs: CMS Seeks MedCAC Members; Two Firms Name Finance Execs; PCORI Senior Advisor

CMS seeks nominees for its Medicare coverage advisory committee. BioDelivery Sciences International, Illuminoss Medical name finance executives. The Patient Centered Outcomes Research Institute taps a senior advisor.

People In Brief

Tactile Systems Technology appoints former Hill Rom CEO Peter S. Soderberg to be chairman. More people briefs.

Table

View full table

Related Content

Medtech Insight

Topics

Related Companies

Tags:
Medical Device
Latest Headlines

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

See All
UsernamePublicRestriction

Register

MT031648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By